ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Andre Terzic
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jovanovic, S.
Right arrow Articles by Terzic, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jovanovic, S.
Right arrow Articles by Terzic, A.

Ann Thorac Surg 1998;66:1658-1661
© 1998 The Society of Thoracic Surgeons

Protective action of 17ß-estradiol in cardiac cells: implications for hyperkalemic cardioplegia

Sofija Jovanovic, DVMa, Aleksandar Jovanovic, MDa, Win K. Shen, MDa, Andre Terzic, MDa

a Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic and Foundation, Rochester, Minnesota, USA

Accepted for publication May 22, 1998.

Address reprint requests to Dr Terzic, Division of Cardiovascular Diseases, Department of Medicine, Guggenheim-7F, Mayo Clinic and Foundation, Rochester, MN 55905

Background. Hyperkalemic cardioplegic solutions effectively arrest the heart, but may also induce intracellular Ca2+ loading and cellular hypercontracture, which could contribute to ventricular dysfunction associated with global surgical ischemia. Recently, it has been proposed that 17ß-estradiol may possess protective properties in the ischemic myocardium. The purpose of the present study was to examine the action of 17ß-estradiol on cardiac cells exposed to hyperkalemic stress.

Methods. Single ventricular cardiomyocytes, a preparation devoid of vascular and neuronal elements, were isolated from guinea pig hearts, loaded with a Ca2+-sensitive fluorescent probe, and imaged by digital epifluorescent microscopy. The emitted fluorescence of the probe, a measure of intracellular Ca2+ concentration, and cell length were simultaneously recorded during hyperkalemic challenge, in the absence or presence of 17ß-estradiol.

Results. In control cardiomyocytes, the cytosolic concentration of Ca2+ was 138 ± 11 nmol/L and cell length 93 ± 11 µm. Exposure to high K+ (+16 mmol/L KCl) significantly increased cytosolic Ca2+ to 2,191 ± 187 nmol/L (p < 0.001), and produced cell shortening (length at 39 ± 5 µm; p < 0.001). 17ß-Estradiol (10 µmol/L) acutely prevented high K+ to induce either intracellular Ca2+ loading (144 ± 13 nmol/L, p < 0.001) or hypercontracture (91 ± 10 µm, p < 0.001). Tamoxifen (10 µmol/L), an antiestrogen, abolished the protective effect of 17ß-estradiol.

Conclusions. We conclude that 17ß-estradiol prevents hyperkalemia-induced Ca2+ loading and hypercontracture through a direct and tamoxifen-sensitive action in cardiomyocytes. This study raises the possibility that 17ß-estradiol should be considered as a cardioprotective adjunct toward a safer hyperkalemic cardioplegia.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
Q. Yang and G.-W. He
Effect of Cardioplegic and Organ Preservation Solutions and Their Components on Coronary Endothelium-Derived Relaxing Factors
Ann. Thorac. Surg., August 1, 2005; 80(2): 757 - 767.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. Mukherjee, W. M. Yarbrough, E. S. Reese, J. S. Leiser, J. A. Sample, J. T. Mingoia, A. E. Hardin, R. E. Stroud, J. E. McLean, J. W. Hendrick, et al.
Myocyte contractility with caspase inhibition and simulated hyperkalemic cardioplegic arrest
Ann. Thorac. Surg., May 1, 2004; 77(5): 1684 - 1689.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Zhai, T. E. Eurell, R. P. Cotthaus, E. H. Jeffery, J. M. Bahr, and D. R. Gross
Effects of dietary phytoestrogen on global myocardial ischemia-reperfusion injury in isolated female rat hearts
Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H1223 - H1232.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. R. Rouleau, A. Dagnault, D. Simard, B. Lavallee, A. Belanger, A. Blouin, and J. G. Kingma Jr.
Effect of estrogen replacement therapy on distribution of myocardial blood flow in female anesthetized rabbits
Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H1407 - H1412.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Zhai, T. E. Eurell, R. Cotthaus, E. H. Jeffery, J. M. Bahr, and D. R. Gross
Effect of estrogen on global myocardial ischemia-reperfusion injury in female rats
Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2766 - H2775.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1998 by The Society of Thoracic Surgeons.